# Neurology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ronald Reagan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML008-SYN
- Date: 2026-02-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rafael Quintero, MD
- Calendar frame: modern shifted

- Requested by: Margaret Ellison, MD

## Reason for consultation

Moderate Alzheimer's disease in a 90-year-old man one month after a fall at home and repair of a right hip fracture. Please confirm the stage, review whether donepezil is still worthwhile given his heart rate and fall risk, and advise on mild evening restlessness without antipsychotics. **S**

## History

Mr. Reagan, a 90-year-old man with Alzheimer's disease diagnosed many years ago, is seen at the request of Dr. Ellison six weeks after a fall at home and internal fixation of a right hip fracture. He takes part in the history as he is able, and his caregivers add detail. Since the hospital oxycodone and diphenhydramine were stopped two weeks ago he sleeps as well as before and has been no more confused. In the evenings he is mildly restless and asks the same questions again; a quiet, unhurried evening routine settles him. He has had no hallucinations, aggression, low mood, fainting, or lightheadedness on standing, and no nausea on donepezil, which he takes each morning. He walks short distances in the house with a front-wheeled walker and standby help and has had no further falls. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert, pleasant, and sociable; cheerful, with no agitation during the visit |
| Mental status | Oriented to person, not to date; tells familiar stories; follows one-step commands |
| Pulse | Regular at 62 per minute |
| Motor | No focal weakness; no rest tremor or rigidity |
| Gait | Stands with arm help and walks with a front-wheeled walker and standby help, steady |

BP 126/72 mmHg; pulse 62 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 96% on room air; weight 76.5 kg; BMI 22.4 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Ellison's first-visit assessment two weeks ago: MoCA 11 of 30, Lawton IADL 1 of 8, Barthel Index 55, GDS-15 4, NPI-Q, a negative Confusion Assessment Method, Timed Up and Go 24 seconds, and seated and standing blood pressure; TSH, blood count, electrolytes, calcium, and kidney function from the same visit; and today's Barthel Index. Barthel Index: 60. All results are synthetic.

## Assessment

1. **Dementia due to Alzheimer's disease, moderate** (F02.B0). FAST stage 5 is confirmed: he needs help choosing clothes and with all instrumental activities, in keeping with a MoCA of 11. The course and examination fit Alzheimer's disease; there are no hallucinations, parkinsonism, or focal signs to suggest another cause. By his caregivers' account he is back to his usual cognition since the sedating hospital medicines were stopped, and there is no delirium. **S**
2. **Donepezil benefit and safety**. Worth continuing. Heart rate 62 with no fainting, no orthostatic drop, and no nausea or weight loss. Stopping a long-standing cholinesterase inhibitor at this stage can bring a noticeable decline. **S**
3. **Evening restlessness and repeated questions**. Mild and settled by routine, with no hallucinations or aggression. Antipsychotics would add risks of falls, stroke, and death in dementia, and sedatives and anticholinergic drugs would add falls and confusion, so none is indicated. **S**
4. **Memantine and further testing**. Memantine is an option at the moderate stage, but adding a medicine during recovery from the fracture is best avoided; revisit at the yearly review. The diagnostic workup was done when the disease was first diagnosed, TSH is normal, and there are no new neurologic signs, so no repeat brain imaging or laboratory workup is needed. At the moderate stage he is outside the eligibility range for anti-amyloid therapy. **S**

## Recommendations

1. Continue donepezil 10 mg each morning; check the pulse at each visit, and reduce or stop it if the heart rate falls below 50 or he faints.
2. Keep the quiet evening routine, with daylight and activity during the day and short, calm answers to repeated questions.
3. No antipsychotic, benzodiazepine, or sedating antihistamine for the restlessness; if it worsens, look first for pain, constipation, infection, or a new medicine.
4. Do not add memantine for now; revisit it at the yearly dementia review.
5. No repeat brain imaging or further laboratory workup unless there is an abrupt change.
6. MoCA, FAST stage, and ADL and IADL scores yearly, and a neuropsychiatric screen at each visit, on the CMID schedule.
7. Walker and standby help for all walking, and supervision at night, because the dementia adds to his fall risk.
8. Continue the home health aide, weekly respite, and Alzheimer's Association support services for his caregivers.

## Strengths and supports

- Supports: spouse, adult children, a long-time aide, and church friends who visit **S**

## Communication

Discussed with Dr. Ellison, who sees him the same day. The plan was explained to Mr. Reagan, as he was able, and to his caregivers. **S**

## Follow-up

Primary care will carry out the monitoring on the CMID schedule. Neurology will see him again for a change in stage, a marked change in behavior, new neurologic signs, or fainting on donepezil. **S**

## Guideline basis

- American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023), American Geriatrics Society
- Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024), Alzheimer's Association
- CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026), Aether Forge
